Combined effect of ALK and MEK inhibitors in EML4-ALK-positive non-small-cell lung cancer cells

J. Tanizaki, I. Okamoto, K. Takezawa, K. Sakai, K. Azuma, K. Kuwata, H. Yamaguchi, E. Hatashita, K. Nishio, P. A. Janne, K. Nakagawa

Research output: Contribution to journalArticlepeer-review

42 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Combined effect of ALK and MEK inhibitors in EML4-ALK-positive non-small-cell lung cancer cells'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science